PharmaBioSource, Inc. has been exclusively retained to seek a partner for a top-notch contract development and aseptic manufacturing operation. Project Orion consists of a number of valuable assets including:
- A modern small-scale commercial aseptic manufacturing and development facility in the U.S. equipped with preparation, formulation, aseptic fill / finish and lyophilization operations.
- Quality control and formulation labs, warehouse and office space are located within the facility.
- Expansion opportunities for additional capacity.
- Well-equipped analytical and development laboratories for small and large molecules.
· $20M+ revenue and $3M EBITDA in 2014.
· Exclusive position with 3 first to file ANDA’s.
Project Orion represents an opportunity to partner with a trusted company seeking leadership in the growing aseptic market place.